Company profile: NxStage
1.1 - Company Overview
Company description
- Provider of medical devices and patient support for kidney failure, fluid overload, and related blood treatments and procedures, including the NxStage System One portable home hemodialysis machine, Liberty Select peritoneal dialysis cycler, Stayβ’safe PIN connectors, and services such as a dialysis center directory, educational webinars, and customer service.
Products and services
- Liberty Select: An acute/chronic-capable peritoneal dialysis cycler used to perform PD therapies across acute and chronic treatment settings
- NxStage System One: A portable hemodialysis machine for home use that enables patients to perform dialysis treatments at home or while traveling, supporting self-administered therapy
- Stayβ’safe PIN connectors: PD-specific connectors used with a peritoneal cycler for the drainage and infusion of peritoneal dialysis solution during dialysis exchanges
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to NxStage
Allena Pharmaceuticals
HQ: United States
Website
- Description: Provider of non-systemic protein therapeutics to treat metabolic and orphan diseases, engaged in development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Allena Pharmaceuticals company profile β
Tricida
HQ: United States
Website
- Description: Provider of pharmaceutical offerings within the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Tricida company profile β
Guard Therapeutics
HQ: Sweden
Website
- Description: Provider of drug candidates for oxidative stress and kidney disease, including RMC-035, a biological therapy mimicking human A1M to prevent acute kidney injury during open-heart surgery, kidney transplantation or sepsis, and GTX-peptider, preclinical A1M fragmentβmimicking peptides intended for chronic treatment of kidney diseases and self-administration via subcutaneous injection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Guard Therapeutics company profile β
LTX
HQ: United States
Website
- Description: Provider of pharmaceutical therapies for critically ill patients, developing an anticoagulant for ICU patients with kidney failure undergoing continuous renal replacement therapy (CRRT), a 24/7 dialysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full LTX company profile β
Gambro
HQ: Sweden
Website
- Description: Provider of medical technology developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Gambro company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for NxStage
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NxStage
2.2 - Growth funds investing in similar companies to NxStage
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for NxStage
4.2 - Public trading comparable groups for NxStage
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β